CV Sciences, Inc. Reports Third Quarter 2017 Financial Results
November 08, 2017 10:00 ET
|
CV Sciences, Inc.
- Record Quarter for all Financial Performance Metrics - Management to Host Webcast on November 8, 2017 to Discuss Q3 2017 Operating Results LAS VEGAS, Nov. 08, 2017 (GLOBE NEWSWIRE) -- CV...
CV Sciences, Inc. to Host Third Quarter 2017 Financial Results Conference Call on Wednesday, November 8, 2017
November 01, 2017 08:45 ET
|
CV Sciences, Inc.
LAS VEGAS, Nov. 01, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent supplier and manufacturer of hemp-derived cannabidiol (CBD) oil...
CV Sciences, Inc. Repays Convertible Debt
October 17, 2017 08:45 ET
|
CV Sciences, Inc.
LAS VEGAS, Oct. 17, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”), market-leading supplier and manufacturer of hemp-derived cannabidiol (CBD)...
CV Sciences, Inc. to Exhibit at the 2017 Academy of Integrative Health & Medicine Annual Conference in San Diego, CA - October 22-25, 2017
October 10, 2017 08:45 ET
|
CV Sciences, Inc.
LAS VEGAS, Oct. 10, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), today announced that its industry-dominating brand of hemp-derived...
CV Sciences, Inc. Announces its Platinum Sponsorship of Natural Products Association Expo Northwest in Portland, OR - October 13-14, 2017
October 03, 2017 08:45 ET
|
CV Sciences, Inc.
LAS VEGAS, Oct. 03, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCBB:CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including CBD oil, announces that its industry...